网关的临床试验。
文章的细节
-
引用
复制到剪贴板 -
贝叶斯M, Rabasseda X, prou照JR
网关的临床试验。
方法找到Exp中国新药杂志。2005年4月,27 (3):193 - 219。
- PubMed ID
-
15834452 (在PubMed]
- 文摘
-
网关是一个临床试验指南最近的临床试验在当前文学和代表大会。以下表中的数据已从临床试验领域的知识检索prou照科学完整性,药物发现和开发门户网站,http://integrity。prous.com。这个问题集中在以下选择的药物:ABX-IL-8,赞誉,adalimumab, agi - 1067, alagebrium氯,阿仑单抗,Alequel,比较,anti-IL-12马伯,大气气溶胶- 9604,阿立哌唑、阿托西汀盐酸盐;两相的胰岛素作为项目,应用波生坦,肉毒杆菌毒素B型,牛乳铁蛋白brivudine;Cantuzumab mertansine, cb - 1954,国开行- 4124,CEA-TRICOM, choriogonadotropin阿尔法,cilansetron, cpg - 10101, cpg - 7909, ctl - 102, ctl - 102 / cb - 1954;DAC:平击,darbepoetin阿尔法,davanat-1 decitabine, del-1 Genemedicine, dexanabinol, dextofisopam, dnaJP1, dronedarone盐酸,dutasteride;Ecogramostim eletriptan,恩曲他滨EPI-hNE-4、eplerenone eplivanserin延胡索酸酯、盐酸埃罗替尼,厄他培南钠、草酸酞,拉唑镁、etoricoxib, ezetimibe;Falecalcitriol fingolimod盐酸盐;Gepirone盐酸盐; HBV-ISS, HSV-2 theracine, human insulin; Imatinib mesylate, Indiplon, insulin glargine, ISAtx-247; L612 HuMAb, levodopa/carbidopa/entacapone, lidocaine/prilocaine, LL-2113AD, lucinactant, LY-156735; Meclinertant, metelimumab, morphine hydrochloride, morphine-6-glucuronide; Natalizumab, nimotuzumab, NX-1207, NYVAC-HIV C; Omalizumab, onercept, osanetant; PABA, palosuran sulfate, parathyroid hormone (human recombinant), parecoxib sodium, PBI-1402, PCK-3145, peginterferon alfa-2a, peginterferon alfa-2b, peginterferon alfa-2b/ribavirin, pemetrexed disodium, pimecrolimus, PINC, pregabalin; Ramelteon, rasagiline mesilate, rasburicase, rimonabant hydrochloride, RO-0098557, rofecoxib, rosiglitazone maleate/metformin hydrochloride; Safinamide mesilate, SHL-749, sitaxsentan sodium, sparfosic acid, SprayGel, squalamine, St. John's Wort extract, synthetic human secretin; Taxus, telavancin hydrochloride, telithromycin, temoporfin, tenofovir disoproxil fumarate, tenofovir disoproxil fumarate/emtricitabine, teriparatide, testosterone gel, TG-1024, tirapazamine, travoprost, travoprost/timolol; Valdecoxib, valganciclovir hydrochloride, voriconazole; Ximelagatran.
DrugBank数据引用了这篇文章
- 药物